Benchmark Reaffirms “Speculative Buy” Rating for Milestone Scientific (NYSE:MLSS)

Benchmark reaffirmed their speculative buy rating on shares of Milestone Scientific (NYSE:MLSS) in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has a $1.25 target price on the stock.

Separately, StockNews.com started coverage on Milestone Scientific in a research note on Monday. They set a “hold” rating on the stock.

Milestone Scientific Trading Up 9.3 %

Shares of MLSS stock opened at $0.68 on Wednesday. The stock has a fifty day simple moving average of $0.84 and a two-hundred day simple moving average of $0.84. Milestone Scientific has a 52-week low of $0.52 and a 52-week high of $1.10.

Insider Activity

In other news, Director Leonard Osser sold 107,984 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the transaction, the director now owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders sold a total of 109,193 shares of company stock worth $101,634 over the last 90 days. Corporate insiders own 24.75% of the company’s stock.

Institutional Investors Weigh In On Milestone Scientific

An institutional investor recently raised its position in Milestone Scientific stock. Geode Capital Management LLC grew its holdings in Milestone Scientific Inc. (NYSE:MLSS) by 6.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 527,005 shares of the company’s stock after purchasing an additional 31,572 shares during the period. Geode Capital Management LLC owned about 0.68% of Milestone Scientific worth $480,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.